News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Trius Therapeutics (TSRX) to Host Analyst and Investor Update Call


11/9/2012 10:20:26 AM

SAN DIEGO, Nov. 8, 2012 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX), a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for life-threatening infections, today announced that it will hold an analyst and investor update call Thursday, November 15, 2012 at 4:15 p.m. Eastern Time (1:15 p.m. Pacific Time). During the call, management will provide commercial and clinical updates for Trius' lead compound, tedizolid phosphate, and Andrew Shorr, MD, MPH from Washington Hospital Center will present his thoughts on the current dynamics in the antibacterial space. The conference call will be webcast live under the Investors section of Trius' website at http://investor.triusrx.com/events.cfm, where it will be archived for 30 days following the call. Please connect to Trius' website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES